Waterlow JC , Garlick PJ, Millward DJ: Protein Turnover in Mammalian Tissues and in the Whole Body. Elsevier, North-Holland, Publ., Amsterdam , 1978
3.
Elwyn DH, Kinney JM, Jeevanandam M., et al: Influence of increasing carbohydrate intake on glucose kinetics in injured patients. Ann Surg190:117, 1979
4.
Robertson RP , Porte D.Jr: Adrenergic modulation of basal insulin secretion in man. Diabetes22:1-8, 1973
5.
Wilmore DW: Hormonal responses and their effects on metabolism. Surg Clin North Am56:999-1018, 1976
6.
Allsop JR, Wolfe RR, Burke JF: Glucose kinetics and responsiveness to insulin in the rat injured by burn . Surg Gynecol Ubstet147:565-573, 1978
7.
Carpentier YA , Askanazi I., Elwyn DH, et al: Effects of hypercaloric infusion on lipid metabolism in injury and sepsis. J Trauma19:649, 1979
8.
Clowes GHA , Randall HT, Cha CJ: Amino acid and energy metabolism in septic and traumatized patients. JPEN4:195, 1980
9.
Dietze G., Wicklmayr M., Hepp KD, et al: On gluconeogenesis of human liver: Accelerated hepatic glucose formation induced by increased precursor supply. Diabetologia12:555-561, 1976
10.
Gerich JE, Lorenzi M., Bier DM, et al: Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. J Clin Invest57:875-884, 1976
11.
O'Keefe SJD , Moldawer LL, Young VR, et al: The influence of intravenous nutrition on protein dynamics following surgery. Metabolism30:1150-1158, 1981
12.
Jeejeebhoy KN, Bruce-Robertson A., Ho J., et al: The comparative effects of nutritional and hormonal factors on the synthesis of albumin, fibrinogen and transferrin. Ciba Foundation Symp9:217-247, 1972
13.
Jeejeebhoy KN, Bruce-Robertson A., Ho J., et al: The effect of cortisol on the synthesis of rat plasma albumin, fibrinogen and transferrin . Biochem J130:533-538, 1972
14.
Gross RL, Newberne PM: Role of nutrition in immunologic function. Physiol Rev60:188, 1980
15.
Waterlow JC , Jackson AA: Nutrition and protein turnover in man. Br Med Bull37:5-10, 1981
16.
Newsholme EA , Start C.: Regulation in Metabolism. John Wiley and Sons, New York, 1976
17.
Beisel WR, Wannemacher RWGluconeogenesis, ureagenesis and ketogenesis during sepsis. JPEN4:277, 1980
18.
Georgieff M. : Theorie und praxis der perioperativen trauma-adaptierten parenteralen naehrstoffzufuhr. Z Ernaehrungswiss21:279-298, 1982
19.
Georgieff M. , Kattermann R., Geiger K., et al: Vergleich von xylit und glukose als energietraeger im rahmen der hypokalorischen postoperativen parenteralen ernaehrungstherapie . Infusionstherapie2:69-76, 1981
20.
Blackburn GL , Flatt JP, Clowes GHA, et al: Protein sparing therapy during periods of starvation with sepsis or trauma. Ann Surg177:588-594, 1973
21.
Georgieff M. , Lutz H.: Die bedeutung des fettstoffwechsels bei der ueberwindung eines traumas. Infusionstherapie9:28-34, 1982
22.
Roth E., Funovics I., Muhlbacher F., et al: Metabolic disorders in severe abdominal sepsis: Glutamine deficiency in the skeletal muscle. Clin Nutr1:25, 1982
23.
Long CL, Jeevanandam M., Kim BM, et al: Whole body protein synthesis and catabolism in septic man. Am J Clin Nutr30:1340, 1977
24.
Kelleher DL , Puinno PA, Fong BC, et al: Glucose and lactate kinetics in septic rats. Metabolism31:252, 1982
25.
Wannemacher RW, Pace JG, Beall FA, et al: Role of the liver in regulation of ketone body production during sepsis. J Clin Invest64:1565, 1979
26.
Wannemacher RW, Kaminski MV Jr, Neufeld HA, et al: Protein-sparing therapy during pneumococcal infection in rhesus monkeys. JPEN2:507-518, 1978
27.
Wolfe RR, Allsop JR, Burke JF: Glucose metabolism in man: Responses to intravenous glucose infusion . Metabolism28:210-220, 1979
28.
Lang K.: Xylit, stoffwechsel und klinische verwendung. Klin Wochenschr49:233-245, 1971
29.
Horecker BL , Lang K., Takagi Y.: Pentoses and Pentitols: International Symposium on Metabolism, Physiology, and Clinical Use. Springer Verlag , New York, 1969
30.
Touster O.: Essential pentosuria and the glucuronate-xylulose pathway. Fed Proc19:977-985, 1960
31.
Baessler KH : Absorption, metabolism and tolerance of polyol sugar substitutes. Pharm Ther Dent3:85-93, 1978
32.
Hollman S., Touster O.: Non-Glycolytic Pathways of Metabolism of Glucose. Academic Press, New York, 1964
33.
Rognstad R. , Wals P., Katz J.: Further evidence for the classical pentose phosphate cycle in the liver. Biochem J208:851-855, 1982
34.
Wannemacher RW Jr, Beall FA, Canonico PG, et al: Glucose and alanine metabolism during bacterial infections in rats and rhesus monkeys . Metabolism29:201-212, 1980
35.
Thompson WL , Wannemacher RWJr: Effects of infection with diplococcus pneumoniae on synthesis of ribonucleic acids in rat liver. Biochem J134:79-87, 1973
36.
Karnovsky ML : Metabolic basis of phagocytic activity. Physiol Rev42:143-168, 1962
37.
Beisel WR, Sawyer WD, Ryll ED, et al: Metabolic effects of intracellular infections in man. Ann Intern Med67: 744-779, 1967
38.
Havel RJ: Caloric homeostasis and disorders of fuel transport. N Engl J Med287:1186-1192, 1972
39.
Ishida T., Chap Z., Chou J., et al: Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs. J Clin Invest72:590-601, 1983
40.
Georgieff M., Geiger K.: Trauma-adapted intravenous nutritional support. IN International Anesthesiology Clinics, European Advances in Intensive Care . Geiger K, (ed). Little, Brown and Company , Boston, 1983
41.
Georgieff M. , Haux P., Raute M., et al: Der einfluss unterschiedlischer infusionsregime auf die hormonelle und metabolische reaktion vor, waehrend und nach cholecystektomie . Infusionstherapie10:11-18, 1983
42.
Sherwin RS, Shamoon H., Hendler R., et al: Epinephrine and the regulation of glucose metabolism: Effect of diabetes and hormonal interactions. Metabolism29:1146-1154, 1980
43.
Flatt JP, Blackburn GL: The metabolic fuel regulatory system: Implications for protein-sparing therapies during caloric deprivation and disease. Am J Clin Nutr27:175-187, 1974
44.
Askanazi J. , Weissman C., Rosenbaum SH, et al: Nutrition and the respiratory system . Crit Care Med10:163-172, 1982
45.
Collins JP, Oxby CB, Hill GL: Intravenous amino acids and intravenous hyperalimentation as protein-sparing therapy after major surgery. Lancet1:788, 1978
46.
Shenkin A., Wretlind A.: Parenteral nutrition. World Rev Nutr Diet28:1, 1978
47.
Baessler KH , Olbermann M.: Kuenstliche ernaehrung. IN Interne Intensivmedizin. Schoelmerich P, Schuster HP, Schonborn H, et al (eds). Stuttgart: Thieme, 1980, pp 85-104
48.
Peter K., Georgieff M., Georgieff EM: Ernaehrung in der intensivmedizin. Intensivmed13:89, 1976
49.
Wolfe RR, Durkot J., Allsop JR, et al: Glucose metabolism in severely burned patients. Metabolism28:1031-1039, 1979
50.
Georgieff M. , Katterman R., Geiger K., et al: Zur Frage der notwendigkeit einer spezifischen postoperativen, totalen parenteralen ernaehrungstherapie nach unterschiedlichen intraabdominellen eingriffen. Infusionstherapie8:114-123, 1981
51.
Mehnert H., Forster H., Geser CA: Clinical use of carbohydrates in parenteral nutrition. IN: Parenteral Nutrition, Meng CH , Laws DH (eds). Charles C Thomas, Springfield, IL, 1970, pp 112-138
52.
Georgieff M. , Katterman R., Geiger K., et al: Unterschiede im postoperativen stoffwechselverhalten bei prae-und postoperativem beginn der totalen parenteralen ernaehrung. I. Mitteilung. Z Ernaehrungswiss18:160-183, 1979
53.
deKalbermatten N., Ravassin E., Jequier E.: Comparison of glucose, fructose, sorbitol and xylitol utilization in man during insulin suppression . Diabetologia13:389, 1977 (abstract)
54.
Georgieff M. , Katterman R., Geiger K., et al: Der postoperative stoffwechselunterschiede zwischen prae-und postoperativem beginn der totalen parenteralen ernaehrung . Anaesth Intensivther Notfallmed15:20-35, 1980
55.
Woolfson AMJ , Heatley RV, Allison SP: Insulin to inhibit protein catabolism after injury. N Engl J Med300:14-17, 1979
56.
Rothig HJ, Stiller N., Dahlmann B., et al: Insulin effect on proteolytic activities in rat skeletal muscle . Horm Metab Res10:101-104, 1978
57.
Loehlein D. , Zick R.: Zuckeraustauschstoffe oder glucose bei der peripher-venoesen hypokalorischen ernaehrung. Infusionstherapie8:133, 1981
58.
Georgieff M. , Katterman R., Lutz H.: IN Hochkalorische Parenterale Ernaehrung , Mueller JM, Pichlmaier H (eds). Springer Verlag, New York, 1981, pp 79-90
59.
Georgieff M. , Geiger K., Bratsch H., et al: The influence of upper and lower abdominal surgery on postoperative liver enzyme changes and protein metabolism during total parenteral nutrition . IN Recent Advances in Clinical Nutrition, I. Howard A, Baird IMcL (eds). John Libbey and Company Ltd., New York, 1981, p 127
60.
Johnson EE, Hedley-Whyte J.: Continuous positive pressure ventilation and portal flow in dogs with pulmonary edema. J Appl Physiol33:385-390, 1972
61.
Georgieff M. , Georgieff E-M., Peter K.: Prae-und postoperative ernaehrung. Aktuelle Ernaehrungsmed1:14, 1976
62.
Loehlein D. : Untersuchungen zum proteinsparenden effekt verschiedener konzepte der peripheren parenteralen ernaehurng. Z Ernaehrungswiss20:1-15, 1980
63.
Bassler VKH : Die rolle der kohlenhydrate in der parenteralen ernaehrung. Parenterale Ernaehrung10:57-72, 1971
64.
Brunzell JD : Use of fructose, xylitol or sorbitol as sweetener in diabetes mellitus . Diabetes Care1:223-230, 1978
65.
Georgieff M. , Storz LW, Lutz H.: Die regulation des ketonkoerperspiegels vor und nach elektiv-chirurgischen eingriffen waehrend unterschiedlicher intravenoeser naehrstoffzufuhr. Z Ernaehrungswiss21:214-224, 1982
66.
de Kalbermatten N., Ravussin E., Maeder E., et al: Comparison of glucose, fructose, sorbitol, and xylitol utilization in humans during insulin suppression. Metabolism29:62-67, 1980
67.
Pellaton M. , Acheson K., Maeder E., et al: The comparative oxidation of glucose, fructose, sorbitol and xylitol in normal man. JPEN2:627-633, 1978
68.
Froesch ER, Zapf J., Keller U., et al: Comparative study of the metabolism of U14C-fructose, U14C-sorbitol and U14C-xylitol in the normal and in the streptozotocin-diabetic rat. Eur J Clin Invest2:8-14, 1971
69.
Ackermann RH : Bestimmung des Xylitumsatzes unter der geburt und nach operationen bei parenteraler zufuhr. Infusionstherapie7:113-115, 1980
70.
Liaw KY, Askanazi I., Michelsen CB, et al: Effect of postoperative nutrition on muscle high energy phosphates . Ann Surg195:12-18, 1982
71.
Georgieff M. , Ackermann RH, Baessler KH, et al: Die vorteile von xylit gegenueber glukose als energietraeger im rahmen der fruhen postoperstiven parenteralen naehrstoffzufuhr. Z Ernaehrungswiss21:27-42, 1982
72.
Georgieff M. : Influence of posttraumatic nutrition in patient outcome. IN New Aspects of Clinical Nutrition, Kleinberger G, Deutsch E (eds). Proceedings of the Fourth Congress of the European Society of Parenteral and Enteral Nutrition, Vienna. Karger, Basel1983, pp 128-138
73.
Zakim D., Hermann RH: Fructose metabolism. II. Regulatory control to the triose level. Am J Clin Nutr21:315-319, 1968
74.
Zakim D., Hermann RH, Gordon WC: The coversion of glucose and fructose to fatty acids in the humans liver. Biochem Med2:427-437, 1969
75.
Baessler KH , Stein G., Belzer W.: Xylitstoffwechsel und xylitresorption: Stoffwechseladaptation als ursache fuer resorptionsbeschleunigung . Biochem Z346:171-185, 1966
76.
Forster H., Hoos J.: Carbohydrate induced increase in uric acid synthesis. Studies in human volunteers and in laboratory rats. Adv Exp Med Biol76A:519-528, 1977
77.
Foerster H. : Energietraeger in der parenteralen ernaehrung: kohlenhydrate, feet, alkohol. Internist19:2-19, 1978
78.
Baessler KH , Brinkrolf H.: Die rolle von oxalacetat bei der gesteigerten ketogenese und beim antiketogenen effekt. Z Ges Exp Med156:52-60, 1971
79.
Blair JB, Cook DE, Lardy HA: Influence of glucagon on the metabolism of xylitol and dihydroxyacetone in the isolated perfused rat liver. J Biol Chem248:3601-3607, 1973
80.
Ravussin E. , Acheson KJ, de Kalbermatten N.: Substrate utilization using indirect calorimetry during xylitol or sorbitol perfusions. Am J Clin Nutr32:1-2, 1979
81.
Lusk G.: Animal calorimetry. Analysis of the oxidation of mixtures of carbohydrate and fat. J Biol Chem59:41-42, 1924
82.
Touster O., Reynolds VH, Hutcheson RM: The reduction of L-xylulose to xylitol by guinea pig liver mitochondria . J Biol Chem221:697-709, 1960
83.
Maekinen KK : Biochemical principles of the use of xylitol in medicine and nutrition with special consideration of dental aspects. Experientia Suppl 30, BirkhaeuseVerlag, Basel, 1978
84.
Maekinen KK : Clinical nutrition: xylitol as a sucrose substitute: relation to dental caries. Nutr Rev39:368-371, 1981
85.
Pitkanen E. , Sohlstrom K.: Increased excretion of xylitol after administration of gluconolactone and ethanol in man. Am Med Exp Fenn47:143-147, 1968
86.
Baessler KH , Toussaint W., Stein G.: Xylit-verwertung bei fruehgeborenen, saeuglingen, kindern und erwachsenen kinetik der elimination aus dem blut. Klin Wochenschr14:212-215, 1966
87.
Sato J., Wang YM, van Eys J.: Metabolism of xylitol and glucose in rats bearing hepatocellular carcinomas . Cancer Research41:3192-3199, 1981 .
88.
Baessler KH: In Metabolism, Physiology and Clinical Use of Pentoses and Pentitols , Horecker BL, Lang K, Takagi Y (eds). 1969 , pp 190-196
89.
Muller F., Strack E., Kuhfahl E., et al: Der stoffwechsel von xylit bei normalen und alloxandiabetischen tieren. Z Ges Exp Med142:238-245, 1967
90.
Winegard AI , Shaw WN: Glucuronic acid pathway activity in adipose tissue. Am J Physiol2061:165-168, 1964
91.
Kuhfahl E.: Der Einflub von monosacchariden und polyalkoholen auf den stoffwechsel unveresterter fettsaeuren des epididymalen fettgewebes normaler und diabetischer ratten . Acta Biol Med Germ21:711-722, 1968
92.
Birnesser H. , Reinauer H., Hollmann S.: Comparative study of enzyme activities degrading sorbitol, ribitol, xylitol and gluconate in guinea pig tissues. Diabetologia9:30-33, 1973
93.
Wang MC, Meng HC: Xylitol metabolism in extrahepatic tissues. Z Ernahrungswiss11:8-16, 1971
94.
Optiz K.: IN Metabolism, Physiology and Clinical Use of Pentoses and Pentitols , Horecher BL, Lang K, Tagaki Y (eds). Springer Verlag, New York, 1969 , pp 238-245
95.
Baessler KH : Die rolle der kohlenhydrate in der parenteralen ernaehrung. Z Ernahrungswiss57:22-27, 1971.
96.
Kaiser W., Stoecker K., Heuckenkamp PU: Human erythrocyte phosphoribosylpyrophosphate content and "generation" during a constant rate infusion of xylitol. Advan Exp Med Biol41:479-482, 1976
97.
Bassler KH, Reimold WV: Lactatbildang aus zuckern und zucker alkoholen in erythrocyten. Klin Wochenschr43:169-176, 1965
98.
Asakura T., Adachi K., Minakami S., et al: Non glucolytic sugar metabolism in human erythrocytes. J Biochem62:184-193, 1967
99.
Baessler KH : Verhandlungen aerztlicher gesellschaften. International symposium on metabolism, physiology and clinical use of pentoses and pentitols (Hakone, Japan). Klin Wochenschr46:279-280, 1968
100.
Hollmann S. : Trennung, reinigung und eigenschaften der mitochondrialen xylit-dehydrogenase zu der meerschweinchenleber. Hoppe-Seylers . Z Physiol Chem317:193-198, 1959
101.
Wang YM, van Eys J.: Nutritional significance of fructose and sugar alcohols. Ann Rev Nutr1:437-475, 1981
102.
Touster O.: Metabolism and physiological effects of the polyols (alditols). IN Physiological Effects of Food Carbohydrates. Jeanes A, Hodge J (eds). American Chemical Society, Washington, DC, 1975, pp 123-134
103.
Hollmann VS , Reinauer H.: Stoffwechsel der Pentosen und pentitole. Z Ernahrungswiss11:1-7, 1971
104.
Baessler KH , Prellwitz W.: Insulin und Verteilungsraum von xylit bei eviszerierten ratten. Klin Wochenschr42:94-100, 1964
105.
Berg G., Bickel H., Matzkies F.: Bilanz und Stoffwechselverhalten von Fruktose, Xylit und Glukose sowie deren mischungen bei Gesunden wahrend sechsstundiger parenteraler Ernahrung . Dtsch Med Wochenschr98:602-610, 1973
106.
Bickel H., Bunte H., Coats DA, et al: Die Verwertung parenteral verabreichter Kohlenhydrate in der postoperativen Phase. Dtsch Med Wochenschr98:809-813, 1973
107.
Black PR, Brooks DC, Bessey PQ, et al: Mechanisms of insulin resistance following injury. Ann Surg196:420-433, 1982
108.
Spitz IM, Rubenstein AH, Bersohn I., et al: Metabolism of xylitol in healthy subjects and patients with renal disease. Metabolism19:24-34, 1970
109.
Brunzell JD : Use of fructose, sorbitol, or xylitol as a sweetener in diabetes mellitus. J Am Diet Assoc73:499-506, 1978
110.
Mueller HR , Geser CA, Bonjour JP: Effects of oral xylitol administration on carbohydrate and lipid metabolism in normal subjects. Infusionstherapie2:247-251, 1975
111.
Hassinger W., Sauer G., Cordes U., et al: The effects of equal caloric amounts of xylitol, sucrose and starch on insulin requirements and blood glucose levels in insulin-dependent diabetics. Diabetologia21:37-40, 1981
112.
Egberts EH, Mueller PH: Kohlenhydratinfusion bei internistischen erkrankungen. Eine vergleichende studie bei stoffwechselgesunden, leberkranken und diabetischen patienten. Infusionstherapie9:166-185, 1982.
113.
Turner RC, Schneeloch B., Nabarro JDN: Biphasic insulin secretory response to intravenous xylitol and glucose in normal, diabetic and obese subjects. J Clin Endocrinol33:301-307, 1971
114.
Matzkies VF : Charakteristische stoffwechselwirkungen von glucose, fructose, sorbit, xylit und deren: mischungen bei intravenoeser dauerinfusion . Z Ernahrungswiss13:113-131, 1974
115.
Matzkies F. : Untersuchungen zur pharmakokinetik von kohlenhydraten als grundlage ihrer anwendung zur parenteralen ernaehrung. Z Ernahrungswiss14:184-216, 1975
116.
Foerster H. , Heller L., Hellmund U.: Stoffwechseluntersuchungen bei kontinuierlicher daurerinfusion von glucose, fructose und xylit ueber 48 studen. Dtsch Med Wochenschr30:1723-1729, 1974
117.
Gruenert A. , Doelp R., und Ahnefeld FW: Sorbit und xylit in der postoperativen infusionstherapie: Dosierungsgrenzen und infusionsdauer . Dtsch Med Wochenschr104:1075-1080, 1979
118.
Berg G., Matzkies F., Heid H., et al: Wirkungen einer kohlenhydratkombinationsloesung auf den stoffwechsel bei gleichzeitiger applikation von aminosaeuren. Z Ernaehrungswiss14:163-174, 1975
119.
Yamagata S. , Goto Y., Ohneda A., et al: Clinical effects of xylitol on carbohydrate and lipid metabolism in diabetes. Lancet2:918-921, 1965
120.
Defronzo RA : Regulation of glucose, lipid, and amino acid metabolism in normal healthy subjects. IN New Aspects of Clinical Nutrition, Kleinberger G, Duetsch E (eds). Karger, Basel, 1983, pp 169-210
121.
Matzkies F. , Grabner W., Scharrer H., et al: Insulin secretion after long-term infusion of xylitol. Horm Metab Res5:221, 1973
Ross BH, Hems R., Krebs HA: The rate of gluconeogenesis from various precursors in the perfused rat liver . Biochem J102:942-951, 1967
124.
Froesch ER , Zapf J., Keller U., et al: Comparative study of the metabolism of U14C-fructose, U14C-sorbitol and U14C-xylitol in the normal and in the streptozotocin-diabetic rat. Eur J Clin Invest2:8-14, 1971
125.
Woods HF, Krebs HA: Xylitol metabolism in the isolated perfused rat liver. Biochem J134:437-443, 1973
126.
Keller U., Froesch ER: Vergleichende untersuchungen ueber den Stoffwechsel von Xylit, Sorbit und Fruktose bein Menschen. Schweiz Med Wochenschr102:1017-1022, 1972
127.
Foerster H. , Meyer E., Ziege M.: Hepatische glykogensynthese in Abhaengigkeit von der blutglucosekonzentration bei narkotisierten ratten . Klin Wochenschr50:478-480, 1972
128.
Dong FM, Hartman WJ, Wekell MM: Effects of dietary xylitol and redox state and gluconeogenesis in the rat liver. J Nutr110 :1274-1284, 1979
129.
Felber JP, Renold AE, Zahnd GR: The comparative metabolism of glucose, fructose, galactose and sorbitol in normal subjects and in disease states. Mod Probl Paedit4:467-489, 1959
130.
Zimmermann HG, Gerlach E.: Stimulation of myocardial adenine biosynthesis by pentoses and pentitols. Pfluegers Arch376:223-227, 1978
131.
Ylikahri RH , Leino T.: Metabolic interactions of xylitol and ethanol in healthy males. Metabolism28:25-29, 1979
132.
Randle RJ, Garland RB, Hales LN, Newsholme EA: The glucose fatty-acid cycle; its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet1:785-789, 1963
133.
Poso AR: Shuttles for translocation of NADH in isolated liver cells from fed rats during oxidation of xylitol. Acta Chem Scand B33:93-99, 1979
134.
Opitz K.: Ueber den einfluss von zuckern, zuckeralkoholen und verwandten substanzen auf die fettmobilisierung. Naunyn-Schmiedebergs Arch Pharmak Exp Path255:192-199, 1966
135.
Petrich V Ch, Reinauer H., Hollmann S.: Vergleichende aktivitaestsmessungen der enzyme des glucuronsaeure-xylulose-zyklus in der leber, dem epididymalen fettgewebe der ratte, in einem Morris-hepatom und einer fibrocyten-kultur . Z Klin Chem Klin Biochem10:355-358, 1972
136.
Baessler KH , Dreiss G.: Antiketogene wirkung von xylit bei alloxandiabetischen ratten. Klin Wochenschr41:593-595, 1963
137.
Hamalainen MM, Makinen KK: Metabolism of glucose, fructose and xylitol in normal and streptozotocin-diabetic rats. J Nutr112:1369-1378, 1982
138.
Jakob A., Williamson JR, Asakura T.: Xylitol metabolism in perfused rat liver. J Biol Chem246:7623-7631, 1971
139.
Moldawer LL , O'Keefe JD, Bothe A. Jr, et al: In vivo demonstration of nitrogen-sparing mechanisms for glucose and amino acids in the injured rat. Metabolism29:173-179, 1980
140.
Duke JH, Jorgensen SB, Broell JR, et al: Contribution of protein to caloric expenditure following injury . Surgery68:168-174, 1970
141.
Williamson JR, Jakob A., Scholz R.: Energy cost of gluconeogenesis in rat liver . Metabolism20:13-26, 1971
142.
Makinen KK : Xylitol and oral health. Adv Food Res25:137-158, 1979
143.
Makinen KK , Virtanen KK: Effects of 4.5 year use of xylitol and sorbitol on plague. J Dental Res57:441-446, 1978
144.
Scheinin A, Makinen KK (eds): Turku sugar studies: I-XXI. Acta Odont Scand33:(suppl 70):1-348, 1975
145.
Matzkies VF : Charakteristiche stoffwechselwirkungen von glucose, fructose, sorbit, xylit und deren mischungen bei intravenoeser dauerinfusion . Z Ernahrungswiss21:113-140, 1974
146.
Mueller PH , Kleber M., Becke F., et al: Kohlenhydratinfusion bei internistischen erkrankungen. Eine vergleichende studie bei stoffwechselgesunden, leberkranken und diabetischen patienten. Infusiontherapie9:112-116, 1982
147.
Prestele H. , Horback L., Malchow H.: Kohlenhydratinfusion bei internistischen erkrankungen. Eine vergleichende studie bei stoffwechselgesunden, leberbranken und diabetischen patienten. VI. Infusion eines glukose/xylit-gemisches (Verhaeltnis 1:1) uber 48 stunden. Infusionstherapie9:92-96, 1982
148.
Ladefoged K., Berthelsen P., Brockner-Nielsen J., et al: Fructose, xylitol and glucose in total parenteral nutrition. Intensive Care Med8:19-23, 1982
149.
Berger W., Goeschke H., Moppert J., et al: Insulin concentrations in portal venous and peripheral venous blood in man following administration of glucose, galactose, xylitol and tolbutamide . Horm Metab Res5:4-8, 1973
150.
Folttmann CH, Reinauer H.: Utilisation von maltose und eines gemisches von maltose mit fruktose und xylit bei parenteraler zufuhr. Infusionstherapie6:84-89, 1979
151.
Coats DA: Long term parenteral nutrition. Z Ernahrungswiss9:401-408, 1969
152.
Schumer W. : Adverse effects of xylitol in parenteral alimentation . Metabolism20:345-347, 1971
153.
Truhaut R. , Coquet B, Fouillet, et al: Sub-acute toxicity of xylitol in rats; absence of hepatotoxicity. Toxicology8:79-85, 1977
